Ka Hortagga Dhaawaca Wadajirka ah Ujeeddada Daaweynta
Sannado badan ka hor, hab daaweyn daaweyn ah oo loogu talagalay rheumatoid arthritis ayaa ah mid caadi ah. Markaa kadib, wax yar ayaa ka sii daray. Si kastaba ha noqotee, hababkan ayaa ka soo wareegay konservative si dagaal ah. Laakiin, maxaa isbedelaya?
Muhiimadda Hore ee Daaweynta Dagaalka
Baaritaanka hore ee rheumatoid arthritis-ka waxaa loo aqoonsan yahay inuu yahay mid muhiim ah sababtoo ah daaweynta hore ee DMARD iyo bayoolojiga ayaa bixiya fursada ugu wanaagsan ee looga hortagi karo dhaawaca wadajir ah, iyo sidoo kale hoos u dhigida khatarta naafonimada iyo dhimashada la xiriirta cudurka.
Sababtoo ah habkaani aadka u daran ayaa ah, markii hore, boqolkiiba halbowlaha bukaanka qaba rheumatoid arthritis ayaa noqday naafo. Nasiib wanaag, maahan dhammaan bukaanka qaba rheumatoid arthritis waxay halis u yihiin dhaawaca daran iyo naafada.
Dadka qaba cudur khafiif ah, daaweynta gardarrada ah uma baahna in la bilaabo. Si kastaba ha ahaatee, halka NSAIDs (daawooyinka nonsteroidal anti-inflammatory) ay caawin karaan calaamadaha rheumatoid arthritis-ka, wax yar maaha inay soo jeediyaan in ay ka hortagaan dhaawaca wadajirka ah.
Qaar yar, haddii ay jiraan, bukaanka qaba rheumatoid arthritis waa musharax loogu talagalay daaweynta NSAIDs kali ah. Caadi ahaan, bukaanka halista hoose u leh dhaawaca wadajirka ah waxaa lagu daaweeyaa daawooyinka DMARD ee hore loogu talagalay in loo arko in ay u yartahay waxyeellooyin yar, oo ay ka mid yihiin:
- Plaquenil (hydroxychloroquine)
- Azulfidine ( sulfasalazine )
- Minocin (minocycline) -Daawada antibiyootigga ee muujisay faa'iidada rheumatoid arthritis, laakiin maaha FDA ansixinta calaamadahan.
Daawooyinka loo isticmaalo arthritis-ga dhexdhexaad ah ama mid daran waxaa ka mid ah kuwan soo socda (oo leh daroogooyinka cusub ee dhuunta):
- Methotrexate (Rheumatrex, Trexall)
- Arava (leflunomide)
- Imuran (azathioprine)
- Xeljanz (tofacitinib)
- Gundhig
- Qaadashada (Infliximab)
- Humira (adalimumab)
- Simponi (golbalab)
- Cimzia (certolizumab pegol)
- Actemra (tocilizumab)
- Rituxan (rituximab)
- Orencia (abatacept)
Bukaanka qaba xanuunka 'rheumatoid' arthritis-ku dhexdhexaad ah ama daran ayaa leh dhibaatooyin badan ama dhibaatooyinka iman kara hawlaha nolol maalmeedka , dhaawaca wadajirka ah iyo hawlaha wadajirka ah. Iyadoo loo eegayo isticmaalka muddada dheer iyo kharash yar, badanaa rheumatologists ayaa ka bilaabi doona daawada methotrexate iyagoo ah DMARD bilowga ah ee bukaanada keena calaamado dhexdhexaad ah ama daran. Prednisone qadar yar ayaa laga yaabaa inay sidoo kale leedahay waxoogaa wax ka bedeleysa cudurka.
Calaamadaha iyo Calaamadaha Dhaawaca Isgaadhsiinta
Natiijooyinka bukaan-socodka oo tilmaamaya khatarta kordhaysa ee dhaawaca wadajirka ah iyo naafonimada xiga waxaa ka mid ah:
- Bararka wadajirka ah
- Adkeysiga dheeraadka ah ee subaxa
- Bilawga rheumatoid arthritis da'da yar
- Antibody-ka sareeya ee CCP
- Caddadka rheumatoid oo aad u sarreeya
- Qalabka Rheumatoid
- Cabbiraadda C-reaktifka (CRP) iyo sicir bararka
- Xasaasiyadda shucaaca (raajada)
Nasiib darro, suurtagal ma ahan in mar kasta la saadaaliyo cidda aan doonaynin ama aysan yeelan doonin waxyeello wadajir ah. Natiijadu, haddii aad leedahay calaamado ama astaamo xanuunka loo yaqaan 'rheumatoid arthritis', hubso inaad la tashanayso rheumatologist si aad u hesho daaweynta kuu fiican.
Daaqada Fursadda
Waxaa jira wakhti go'an oo lagu daaweynayo rheumatoid arthritis-ku uu leeyahay saameynta ugu weyn ee koritaanka cudurka.
Fikradda ugu weyn ee saameynta ugu weyn waxay noqon kartaa rheumatoid arthritis remission ama ugu yaraan saameyn ku yeelanaya horumarka cudurka kaas oo ka muuqda raajada ama hawl wadajir ah. Tan waxaa loo yaqaan "Window of Opportunity" oo cilmi-baarayaashu ay wax badan ka bartay, daaqadda ayaa cidhiidhi gashay.
Xaaladda degdegga ah ee daaweynta hore ee rheumatoid arthritis-ka ayaa ah mid cad. Aragtida ugu dambaysa ee marka la eego marka daaweynta gardarrada ah la bilaabi doono waa "horaantii si fiican."
Si xiiso leh, iskuday inaad hoos u dhigto marka daaqada fursadda ay furto oo ay xirto bukaanka shakhsiga ah looma arkin inuu yahay wax faa'iido leh.
Hase yeeshee, ma jirto wax diidaya in cudurkan loo xakameeyo sida ugu dhakhsaha badan waa ujeedada cad. Taas macnaheedu waxa weeye daaweynta arthritis-ka aan kala go 'lahayn , xaaladaha qaarkood, iyadoo rajo ka dhigaysa in ay joojiso sii socodsiinteeda uurjiifka rheumatoid buuxa.
Ilaha:
Daaqadda daaweynta ee fursada ku jirta rheumatoid arthritis: miyey weligeed isku dhowdahay? Karim Raza, Andrew Filer. Annals of Cudurada Rheumatic. Maarso 10, 2015.
Ciladeynta Arthritis Early Early Rheumatoid. Bogga 73. Rheumatoid Xanuunka Arthritis: Early Diagnosis and Treatment. Saddexaad. Cush, Weinblatt, Kavanaugh. Xiriirka Xirfadaha, Inc.